Company intelligence / Profile preview
Matter Bio
Brooklyn or New York City, New York, United Statesmatterbio.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
Early-stage company with no reported clinical results yet. Seed funding will support IND-enabling studies and first-in-human trials targeting solid tumors using their genome integrity restoration approach.
- Therapeutic areas
- OtherOncology
- Modalities
- Genomic repair/enhancement technologiesAttenuated bacterial therapeutics (for cancer)Computational biology approaches to genome stability
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Lifespan Vision VenturesquadraScope Ventures—investors with strategic interest in longevity biotech. Early-stage collaborations mentioned but specific partners not named.
Beyond the preview
Go deeper on Matter Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Matter Bio.